Associated Papers
Impact of Clinicopathological Characteristics and Tissue Inhibitor of Metalloproteinase-3 Polymorphism Rs9619311 on Biochemical Recurrence in Taiwanese Patients with Prostate Cancer.
Hsieh CY et al.
International Journal of Environmental Research and Public Health, 2022
The polymorphisms of extracellular matrix-remodeling genes are associated with pelvic organ prolapse.
Li L et al.
International Urogynecology Journal, 2022
34973089 (PubMed )
Supplement: 192_2021_4917_MOESM1_ESM.xls › Sheet1
Associations of TIMP-3 Genetic Polymorphisms with EGFR Statuses and Cancer Clinicopathologic Development in Lung Adenocarcinoma Patients.
Chang JH et al.
International Journal of Molecular Sciences, 2020
Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer.
Su CW et al.
Medicine, 2015
Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms.
Krex D et al.
Stroke, 2003
Systematic search for mutations in the human tissue inhibitor of metalloproteinases-3 (TIMP-3) gene on chromosome 22 and association study with schizophrenia.
Hung CC et al.
American Journal of Medical Genetics, 2001
Select a paper to view details